Abstract: The present invention relates to a composition, a kit, and a method of providing information for diagnosis, which are capable of diagnosing pancreatic cancer and capable of diagnosing pancreatic cancer by distinguishing it from other pancreatic diseases or other cancer types.

Abstract: The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for inhibiting ATX. Also provided are methods of preparing said compounds and compositions, and synthetic precursors of said compounds.

Abstract: A battery diagnosis apparatus for diagnosing a battery including battery cells, the apparatus according to an embodiment may include a voltage measurer for measuring the voltage of each battery cell during a preset period of time, a voltage variation calculator for calculating an individual voltage variation of each battery cell during the preset period of time, an average voltage variation calculator for calculating an average voltage variation of the battery cells during the preset period of time, and an abnormality detector for determining that a voltage abnormality has occurred in at least one battery cell among the battery cells when a difference between the voltage variation of the at least one battery cell and the average voltage variation of the at least one battery cell is greater than a threshold value.

Abstract: According to the embodiment of the present disclosure, an organo tin compound is represented by the following Chemical Formula 1: In Chemical Formula 1, L1 and L2 are each independently selected from an alkoxy group having 1 to 10 carbon atoms and an alkylamino group having 1 to 10 carbon atoms, R1 is a substituted or unsubstituted aryl group having 6 to 8 carbon atoms, and R2 is selected from a substituted or unsubstituted linear alkyl group having 1 to 4 carbon atoms, a branched alkyl group having 3 to 4 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, and an allyl group having 2 to 4 carbon atoms.

Abstract: Proposed are a seat side bolster apparatus and a control method thereof. The seat side bolster apparatus of the disclosure includes a driving unit, which is provided under a foam pad of a seat cushion, is moved upwards and downwards by operation of an actuator, and presses the foam pad upwards when moving upwards, and a covering bracket, which is connected to the driving unit so as to be moved upwards and downwards together with the driving unit and to which an end of a covering enveloping the foam pad of the seat cushion is fixed.

Abstract: A light-emitting element includes a first semiconductor layer, a light-emitting layer disposed on the first semiconductor layer, a second semiconductor layer disposed on the light-emitting layer, a device electrode layer disposed on the second semiconductor layer, a reflective electrode layer disposed on the device electrode layer, an insulating film surrounding a side surface of the light-emitting layer, a side surface of the second semiconductor layer, and a side surface of the device electrode layer, and a reflective layer surrounding a side surface of the insulating film, wherein the side surface of the device electrode layer is aligned with a side surface of the reflective electrode layer.

Abstract: Disclosed are a circuit and a system which is capable of improving reliability by preventing destructive overvoltage that occurs in an element using a low power supply voltage when various signals are transmitted from an integrated circuit with a high power supply voltage to an integrated circuit with a low power supply voltage.

Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. Since the heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, the heteroaryl derivative can be usefully used as a therapeutic agent for EGFR-associated diseases.

Abstract: The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.

Abstract: An emergency lamp includes a housing assembly; a battery module; a control panel; a lighting assembly; a heat sink configured for heat dissipation for the lighting assembly; a light guide assembly; and a transparent cover. The battery module includes a bracket, a battery disposed on the bracket, and a cladding layer wrapping around the battery. The housing assembly is a hollow structure, and the battery module, the control panel, and the lighting assembly are disposed in the housing assembly. The light guide assembly is connected to the lighting assembly. The transparent cover is disposed on the housing assembly; a position of the transparent cover corresponds to that of the light guide assembly. The battery module is electrically connected to the control panel, and the lighting assembly is electrically connected to the control panel; and the housing assembly including a hole for fixing a waterproof joint.

Abstract: An emergency lamp includes a housing assembly; a battery module; a control panel; a lighting assembly; a heat sink configured for heat dissipation for the lighting assembly; a light guide assembly; and a transparent cover. The battery module includes a bracket, a battery disposed on the bracket, and a cladding layer wrapping around the battery. The housing assembly is a hollow structure, and the battery module, the control panel, and the lighting assembly are disposed in the housing assembly. The light guide assembly is connected to the lighting assembly. The transparent cover is disposed on the housing assembly; a position of the transparent cover corresponds to that of the light guide assembly. The battery module is electrically connected to the control panel, and the lighting assembly is electrically connected to the control panel; and the housing assembly including a hole for fixing a waterproof joint.

Abstract: The disclosure provides antibodies that specifically bind human MICA/B and methods of use thereof. In some aspects, the disclosure is directed to methods of treating a cancer in a subject, comprising administering to the subject an anti-MICA/B antibody.

Abstract: The present disclosure provides variant forms of anti-CTLA-4 antibodies, such as ipilimumab, that preferentially bind to CTLA-4 at low pH. Such antibody variants exhibit preferential activity in the tumor microenvironment, an enhanced ratio of anti-tumor response to side-effects, and an enhanced therapeutic index.

Abstract: The disclosure provides antibodies that specifically bind human MICA/B and methods of use thereof. In some aspects, the disclosure is directed to methods of treating a cancer in a subject, comprising administering to the subject an anti-MICA/B antibody.

Abstract: The present disclosure provides a hybrid suspension arm for a vehicle, having excellent durability. A hybrid suspension arm for a vehicle according to one embodiment of the present disclosure comprises: a suspension arm body which is made of metal material and comprises a top plate part and two sidewall parts extending downward from the top plate part to be open downward; and an insert molding which is made of plastic material and is formed by being insert-molded in the suspension arm body, wherein a thickness of at least a portion in the portion of the insert molding that comes in contact with the top plate part and the sidewall parts is in the range of 2 mm to 3 mm.

Abstract: A vehicular hybrid suspension arm includes a suspension arm body made of a steel material, and an insert molding inserted into and coupled to the suspension arm body, providing a suspension arm having reduced weight and high rigidity.

Abstract: A hybrid lower arm and a hybrid upper arm include an arm body made of a metal material, and an insert injection-molded integrally with the arm body so that the insert is inserted into an inside of the arm body. The arm body has a weight ratio of 50% or more and 90% or less with respect to the total weight of the hybrid lower arm or the hybrid upper arm, thus achieving the rigidity increase as well as the weight reduction in the lower arm and the upper arm of a suspension system.

Abstract: The present disclosure provides a hybrid suspension arm for a vehicle, having excellent durability. A hybrid suspension arm for a vehicle according to one embodiment of the present disclosure comprises: a suspension arm body which is made of metal material and comprises a top plate part and two sidewall parts extending downward from the top plate part to be open downward; and an insert molding which is made of plastic material and is formed by being insert-molded in the suspension arm body, wherein a thickness of at least a portion in the portion of the insert molding that comes in contact with the top plate part and the sidewall parts is in the range of 2 mm to 3 mm.

Abstract: The present disclosure provides a hybrid suspension arm for a vehicle, the hybrid suspension arm having the strength required for a vehicle while being lightweight and having excellent durability. The hybrid suspension arm for a vehicle according to one embodiment of the present disclosure comprises: an arm body comprising aluminum; and an insert molding part made of plastic material which is insert-molded on the arm body and coupled thereto.

Abstract: The disclosure provides antibodies that specifically bind human MICA/B and methods of use thereof. In some aspects, the disclosure is directed to methods of treating a cancer in a subject, comprising administering to the subject an anti-MICA/B antibody.